Related references
Note: Only part of the references are listed.The Associations between Metalloestrogens, GSTP1, and SLC11A2 Polymorphism and the Risk of Endometrial Cancer
Kaja Michalczyk et al.
NUTRIENTS (2022)
Immune infiltration and a ferroptosis-associated gene signature for predicting the prognosis of patients with endometrial cancer
Yin Weijiao et al.
Aging-US (2021)
Transcription factor AP-4 (TFAP4)-upstream ORF coding 66 aa inhibits the malignant behaviors of glioma cells by suppressing the TFAP4/long noncoding RNA 00520/microRNA-520f-3p feedback loop
Yipeng Wang et al.
CANCER SCIENCE (2020)
Magnitude of benefit of the addition of poly ADP-ribose polymerase (PARP) inhibitors to therapy for malignant tumor: A meta-analysis
Lihu Gu et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)
Oncogenic and drug-sensitive RET mutations in human epithelial ovarian cancer
Luyao Guan et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Identification of Hub Genes in High-Grade Serous Ovarian Cancer Using Weighted Gene Co-Expression Network Analysis
Meijing Wu et al.
MEDICAL SCIENCE MONITOR (2020)
Deferoxamine-induced high expression of TfR1 and DMT1 enhanced iron uptake in triple-negative breast cancer cells by activating IL-6/PI3K/AKT pathway
Chunli Chen et al.
ONCOTARGETS AND THERAPY (2019)
Sialyl Lewisx-P-selectin cascade mediates tumor-mesothelial adhesion in ascitic fluid shear flow
Shan-Shan Li et al.
NATURE COMMUNICATIONS (2019)
Deferoxamine Enhanced Mitochondrial Iron Accumulation and Promoted Cell Migration in Triple-Negative MDA-MB-231 Breast Cancer Cells Via a ROS-Dependent Mechanism
Chunli Chen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Epigenetic therapy for ovarian cancer: promise and progress
Sara Moufarrij et al.
CLINICAL EPIGENETICS (2019)
Health-related quality of life and patient-centred outcomes with olaparib maintenance after chemotherapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT Ov-21): a placebo-controlled, phase 3 randomised trial
Michael Friedlander et al.
LANCET ONCOLOGY (2018)
Ionophores: Potential Use as Anticancer Drugs and Chemosensitizers
Vivek Kaushik et al.
CANCERS (2018)
The Fallopian Tube Origin and Primary Site Assignment in Extrauterine High-grade Serous Carcinoma: Findings of a Survey of Pathologists and Clinicians
W. Glenn McCluggage et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2017)
Toil enables reproducible, open source, big biomedical data analyses
John Vivian et al.
NATURE BIOTECHNOLOGY (2017)
Nerve growth factor and its receptors on onset and diagnosis of ovarian cancer
Xiaolin Yu et al.
ONCOLOGY LETTERS (2017)
Endoplasmic reticulum stress promotes autophagy and apoptosis and reverses chemoresistance in human ovarian cancer cells
Jin-Long Hu et al.
ONCOTARGET (2017)
Iron Uptake via DMT1 Integrates Cell Cycle with JAK-STAT3 Signaling to Promote Colorectal Tumorigenesis
Xiang Xue et al.
CELL METABOLISM (2016)
Deferoxamine regulates neuroinflammation and iron homeostasis in a mouse model of postoperative cognitive dysfunction
Yuping Li et al.
JOURNAL OF NEUROINFLAMMATION (2016)
The role of surgery in advanced epithelial ovarian cancer
Maria Martin-Camean et al.
ECANCERMEDICALSCIENCE (2016)
Fimbrial Cells Exposure to Catalytic Iron Mimics Carcinogenic Changes
Debora Lattuada et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2015)
A multicenter, randomized trial of flat dosing versus intrapatient dose escalation of single-agent carboplatin as first-line chemotherapy for advanced ovarian cancer: an SGCTG (SCOTROC 4) and ANZGOG study on behalf of GCIG
S. Banerjee et al.
ANNALS OF ONCOLOGY (2013)
The Ferric Enterobactin Transporter Fep Is Required for Persistent Salmonella enterica Serovar Typhimurium Infection
Toni A. Nagy et al.
INFECTION AND IMMUNITY (2013)
Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research
Emma Kipps et al.
NATURE REVIEWS CANCER (2013)
The DNA damage response and cancer therapy
Christopher J. Lord et al.
NATURE (2012)
Iron transporter Nramp2/DNTT-1 is associated with the membrane of phagosomes in macrophages and Sertoli cells
N Jabado et al.
BLOOD (2002)